OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

Charity registration number 1156435 (England and Wales)

INTERNATIONAL MENOPAUSE SOCIETY

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

INTERNATIONAL MENOPAUSE SOCIETY

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Prof N Panay Prof A Vincent Prof W Wolfman Prof T Simoncini Dr N Jaff Prof P Chedraui Prof S Palacios Prof A Seng Bin Prof P Maki Prof R Nappi Prof S Goldstein Dr T Hillard (Appointed 22 October 2024) Prof P Damodaran (Appointed 22 October 2024) Prof A Cano (Appointed 22 October 2024) Prof S Khandelwal (Appointed 22 October 2024) Prof M Shapiro Dr P Schnatz (Appointed 22 October 2024) Senior management R Cheshire Chief Executive Officer Charity registration England and Wales 1156435 Principal address 13 Leechwell Street Totnes Devon TQ9 5SX Independent examiner Haines Watts Swindon Limited Old Station House Station Approach Swindon Wiltshire SN1 3DU

INTERNATIONAL MENOPAUSE SOCIETY

CONTENTS

Page
Trustees' report 1 - 8
Independent examiner's report 9
Statement of financial activities 10
Balance sheet 11
Statement of cash flows 12
Notes to the financial statements 13 - 22

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 DECEMBER 2024

The trustees present their annual report and financial statements for the year ended 31 December 2024.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".

The International Menopause Society (IMS) has been registered as a Charitable Incorporated Organisation (CIO) with The Charity Commission of England and Wales since 28th March 2014. The organisation is governed by its Constitution and Rules. The Board of Directors of the charity are its Trustees for the purposes of charity law and throughout this report are collectively referred to as Trustees.

The IMS was founded in 1978 and aims to promote education, study, and research into midlife women's health. It organises, prepares, and contributes to international meetings and congresses on menopause and encourages the interchange of research and knowledge between individual members. Membership of the IMS is open to health care professionals with an interest in menopause and midlife women’s health, and national/regional menopause societies via its Council of Affiliated Menopause Societies (CAMS). Individual members represented 94 countries and CAMS members represented 64 countries/regions. The IMS actively supports the establishment of menopause societies in countries/regions where there are none via the implemnentation of its Toolkit for Starting a Menopause Soceity.

Objectives and activities

The principal object of the organisation as set out in its Constitution is: the relief of sickness and the preservation and protection of good health by the promotion and co-ordination of information, education and scientific studies of the health and well-being of peri- and post-menopausal women during and after mid-life. This object is encapsulated within the IMS Mission and Vision Statements, which were updated in December 2019.

The MISSION of IMS is to work globally to promote and support access to best practice health care for women through their menopause transition and post-reproductive years, enabling them to achieve optimal health and wellbeing.

The VISION of the IMS is that all women across the world will have easy and equitable access to evidence-based knowledge and health care, empowering them to make fully informed mid-life health choices.

Strategies for achieving aims and objectives

The IMS plans and reviews its strategic objectives and activities via a strategic planning cycle. The organisation's primary work to deliver its mission and vision include:

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Public benefit

The primary focus of the IMS’s work aligns with our charitable purpose of delivering public benefit. We annually evaluate our initiatives to ensure they effectively contribute to improving health care standards for mid-life women and remain aligned with our mission. Planned activities are carefully assessed to support our overarching aims and objectives.

Activities

The IMS’s activities center on promoting menopause awareness and equipping health care professionals with the knowledge to improve understanding and treatment of the condition. These efforts are integral to fulfilling our charitable objectives for public benefit. Regular reviews of our work help us assess its impact and ensure alignment with our goal of advancing health standards for midlife women. Planned initiatives are designed to meaningfully contribute to our established goals.

Achievements and performance

Significant activities and achievements against objectives IMPART

The International Menopause Society Professional Activity for Refresher Training (IMPART) is the first educational initiative pertaining to menopause that is internationally applicable to health care professionals working in, or with a special interest in, mid-life women's health. It is aligned with the IMS’s mission to work globally to promote and support access to best practice health care for women through their menopause transition and post-reproductive years, enabling them to achieve optimal health and well-being. The Level 1 course was developed in June 2017 and updated in July 2020. The Level 2 course was launched on 18th October 2021.

Level 1 has been translated into Spanish, Portuguese, Chinese, Vietnamese, Arabic and Russian. Level 1 and the first five modules of Level 2 are available on the learning platform. Certificates of completion are provided for both levels, one-year free Limited Professional Membership to the IMS is awarded with completion of Level 1. As of 31st December 2024 there were 12,715 registrations for Level 1 and 618 registrations for Level 2. Registrants were from 127 countries.

Online Education Events

The IMS produced a wide range of online educational resources in 2024, including live webinars, interviews in video and podcast formats (for professionals and for women), the Council of Affiliated Menopause Societies (CAMS) Menopause Hour webinars and the Clinical Colloquium in Menopause and Midlife Women’s Health.

The objective of all online resources is to provide scientific information, including potential treatment and management, thereby increasing the participants’ and viewers’ knowledge and practical skills in providing best practice care for women in midlife and beyond. Nine webinars, fourteen interviews (two versions for each of the ten different topics), seven CAMS Menopause Hour webinars and five Clinical Colloquium sessions were delivered in 2024. These are listed on the following pages.

The recordings of all of these resources are available for free on the IMS website, YouTube channel, and podcast platforms.

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

Webinars

Title: Approach to Bone Health in the Perimenopause and Post Menopause Moderator: Steven Goldstein Speakers: Michael McClung and Aliya Khan -----------------------------------------------------------------------------------------------------Title: Hormones and Stroke: An update on treatment and risk Moderator: Antonio Cano Speakers: Matthew Nudy and Dominique Cadilhac -----------------------------------------------------------------------------------------------------Title: Non-hormonal pharmacological interventions for VMS Moderator: Wendy Wolfman Speakers: Chrisandra Shufelt and Petra Stute -----------------------------------------------------------------------------------------------------Title: Non-pharmacological Interventions for VMS Moderator: Pauline Maki Speakers: Myra Hunter and Gary Elkins -----------------------------------------------------------------------------------------------------Title: Perimenopausal Contraception Moderator: Rossella Nappi Speakers: Andrew Kaunitz and Pelin Batur -----------------------------------------------------------------------------------------------------Title: Sexual Dysfunctions, Update on Gynae Cancers and Management Moderator: Johannes Bitzer Speakers: Mike Krychman and Sheryl Kingsberg -----------------------------------------------------------------------------------------------------Title: Skin Ageing Moderator: Jennifer Allen Speakers: Mark Brincat -----------------------------------------------------------------------------------------------------Title: Menopausal Migraines Moderator: Antonio Cano Speakers: Raffaele Ornello and Rossella Nappi -----------------------------------------------------------------------------------------------------Title: Recommendations on Cardiovascular Risk Assessment Moderator: Matthew Nudy Speakers: Serenella Castelvecchio and Rosanna Tavella Clinical Colloquium

Title: Premature ovarian insufficiency: Unique and underappreciated Speaker: Nick Panay

--------------------------------------------------------------------------------------------------------Title: Obesity and its emerging importance in midlife women Speaker: Ang Seng Bin

--------------------------------------------------------------------------------------------------------Title: A midlife women’s health unit: How to organize it Speaker: Wendy Wolfman

--------------------------------------------------------------------------------------------------------Title: How to diagnose and treat sexual symptoms associated with menopause Speaker: Rossella Nappi

--------------------------------------------------------------------------------------------------------Title: Ultrasound in Midlife Women: Whether you order or perform it Speaker: Steven Goldstein

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Interviews Title: Genitourinary Syndrome of Menopause Interviewee: Jan Shifren --------------------------------------------------------------------------------------------Title: Title: Preventing Bone Loss at Menopause Interviewee: Michael McClung --------------------------------------------------------------------------------------------Title: Title: Metabolic Syndrome in Midlife Women Prof Antonio Cano Interviewee: Antonio Cano --------------------------------------------------------------------------------------------Title: Title: Preventing Bone Loss at Menopause Interviewee: Michael McClung --------------------------------------------------------------------------------------------Title: Title: Vulvar Diseases, Overview for Aging Women Interviewee: Celine Bouchard --------------------------------------------------------------------------------------------Title: Title: Impending Menopause: How can fertility be preserved? Interviewee: Duru Shah --------------------------------------------------------------------------------------------Title: Title: Menopause and Hormone Therapy: Current perspectives Interviewee: Nick Panay CAMS Menopause Hour Webinars

Swiss & German Menopause Societies Title: Perimenopause: A clinical challenge Moderator: Susanna Weidlinger Speakers: Katrin Schaudig and Annette Bachmann ---------------------------------------------------------------------------------------------------------------------------Italian Menopause Society Title: The Clinical Management of the Risk of Postmenopausal Osteoporosis Moderator: Angelo Cagnacci Speakers: Marco Gambacciani and Stefano Lello ---------------------------------------------------------------------------------------------------------------------------Canadian Menopause Society Title: A Practical Approach to the Management of Menopause Moderator: Denise Black Speakers: Ardelle Piper and Denise Black ---------------------------------------------------------------------------------------------------------------------------European Menopause and Andropause Society Title: Promoting Menopause Health: Cardiometabolic and Vasomotor Symptoms Moderator: Dimitrios Goulis Speakers: Antonio Cano and Eleni Armeni ---------------------------------------------------------------------------------------------------------------------------Mexican Menopause Society Title: Genitourinary Syndrome of Menopause Moderator: Victor Manuel Vargas Hernandez Speakers: Erika Torres Valdez, Gerardo Andres Alba Jasso, and Victor Manuel Vargas Aquilar ----------------------------------------------------------------------------------------------------------------------------

Brazilian Menopause Society Title: Challenges in Caring for Climacteric Women Moderator: Nilson Roberto de Melo Speakers: Rogerio Bonassi Machado and Marie Celeste Wender

Indian Menopause Society Title: Genitourinary Health Moderators: Meeta Singh, Ambuja Choranur, Neelam Aggarwal Speakers: Archana Dwivedi, Anju Soni and Asna Ashraf

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

World Congress on Menopause

The 19th World Congress on Menopause was held in Melbourne, Australia on 19th-22nd October 2024. The event attracted 2,548 attendees from 77 countries. The scientific programme was delivered by 412 of the world’s emerging and leading experts on menopause and midlife women’s health and was comprised of a Pre-Congress Course, 21 Oral Communications sessions, 21 Symposia delivered by CAMS members, 19 Symposia, 11 Meet the Expert sessions, 10 Plenary Lectures, 10 Sponsored Symposia, three Debates, the Menopause Olympics and a poster session. Fifty four bursaries to individuals from 25 countries were awarded via the IMS Young Scholars Bursary programme. The bursary included complimentary registration to the Congress, financial support for travel and accommodation, opportunities to participate in the scientific programme (Menopause Olympics and co-chairing sessions), a complimentary one-year membership to the International Menopause Society.

World Menopause Day

World Menopause Day is held every year on the 18th of October. The day was designated by the IMS and the World Health Organization (WHO) to raise awareness of menopause and to support options to improve health and well-being for women in mid-life and beyond. Every year, the IMS selects a theme and publishes a White Paper, leaflets for consumers and an Engagement Toolkit. Organisations, professionals and women are encouraged to participate in this global awareness-raising campaign by sharing the educational resources, organising events and engaging with social media posts.

The theme of World Menopause Day 2024 was ‘Menopause Hormone Therapy’. The resources were translated into thirteen languages. The White Paper was published online and in print in the IMS journal, Climacteric.

Climacteric

Climacteric is the official journal of the IMS. As an international peer-reviewed journal, it publishes original research and reviews of all aspects of aging in women. Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on menopause and mid-life women’s health. Climacteric is published bi-monthly.

The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and was headed by Dr Timothy Hillard (UK). The Editor and team of Associate Editors acted independently to set a clear editorial process, co-ordinate peer reviews, and ensure a rapid response to submitted papers.

Endowment for Education and Research (EER)

The EER builds on the organisation’s well-established history of funding endeavours that promote education and research. This has included the Research Bursary, World Congress Travel Bursaries, and monetary prizes for IMS Awards. With the EER, the Board of Directors recognise the important role that funding plays in supporting vital initiatives to increase awareness and knowledge of menopause and mid-life women’s health. The EER was established on 4th August 2022, with the Young Scholars’ Bursary for the 18th World Congress on Menopause in Lisbon, Portugal as the first funded project. In 2024, the EER funded Young Scholars’ Bursaries for 54 individuals to support attendance and participation at the 19th World Congress on Menopause in Melbourne, Australia. In addition to the IMS’s own financial contributions to the EER, it secures unrestricted funds via a variety of sources, including grants and donations. In addition to generating funds, this brings broader opportunities to grow support for the organisation’s mission and to build partnerships.

Menopause Info

Menopause Info is the IMS educational resource for women. It provides reliable information about menopause and midlife women’s health from the world’s leading experts. The content is curated and developed by the IMS with the aim to ensure that trusted, scientifically evidenced information is easily accessible to women across the globe. The resources published in 2023 include factsheets and expert interviews.

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Financial review

The financial position of the charity at the year end is set out on page 13.

The Trustees have a reasonable expectation that the charity has adequate resources to continue in operation for the foreseeable future. The biennial World Congress, the primary income generating activity for the organisation, was held in 2024. The first half of the profit from this event was received in 2024, with the second half of the profit to be paid by the Professional Congress Organiser in 2025. The organisation achieved an in-year surplus of £41,829. The total funds carried forward for the year is £1,668,922 of which £21,576 are restricted funds.

Reserves policy

The Society has a reserves policy whereby the organisation seeks to hold reserves sufficient to meet one year's operating costs of £750,000 during a period of difficulty plus an additional amount of £500,000 to cover potential costs not recoverable through insurance (for example, due to a pandemic or other force majeure) in the event of a cancelled World Congress, our main source of income.

The Trustees have agreed that the remaining unrestricted funds will be used to support the charity’s strategic priorities, including the recruitment of additional staff and support services during 2025, and the provision of educational bursaries for early career professionals and academic awards associated with the 2026 World Congress.

The Trustees consider this level and planned use of reserves to be appropriate to safeguard the charity’s activities and to enable continued delivery of its charitable objectives.

The finance subcommittee of Trustees reviews the reserves policy on an annual basis. At the year-end free reserves (unrestricted funds less designated funds and functional fixed assets) amounted to £1,647,346 (2023 £1,551,081).

Major risks

As part of the periodical strategic review, the Trustees identify major risks to the Society and take steps to mitigate the identified risks. The Board of Trustees have an ongoing brief to review all risks and assess them on a regular basis to ensure that their financial or ethical impact have been identified and monitored. All financial impacts are reviewed regularly by the Finance Committee, chaired by the Treasurer. The Society does not anticipate any factors likely to affect future performance, other than cancellation or disruption of a World Congress. Reserves are designed to cover running costs to ameliorate this potential risk, and insurance is in place to recuperate any potential losses from a World Congress.

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Plans for future periods

The IMS Strategic Plan for 2022-2026 sets out the following strategic goals for the organisation:

1. Broadening Our Reach

The IMS delivers a valued offering to benefit women’s health in midlife and during the menopause transition. We offer a range of products and benefits and the information we disseminate is evidence-based and comes from trusted sources. Given this offer, increasing awareness of its importance, and the need to counteract misinformation in this arena, we want to reach more women and professionals working with women.

This will be achieved by:

2. Increasing Our Impact

We want women to achieve optimal health and wellbeing through their menopause transition and post-reproductive years. To this end, what we deliver should have maximum impact on all our audiences by increasing visibility, continuous improvement and evidencing the quality of our educational offerings.

This will be achieved by:

3. Diversifying Our Resources

Given the rapidly changing external landscape within which we operate, as well as emerging needs and the new ways in which people engage with information, we are committed to ensuring we adapt and remain responsive to the needs of all our stakeholders so they can access trusted and valuable information. We will secure funding and engage with new partners to support us to do this

This will be achieved by:

Structure, governance and management

IMS legal seat and charitable registration has been in England and Wales when accepted by the Charity Commissions as a Charitable Incorporated Organisation (CIO) on 28th March 2014, with a registered charity number of 1156435.

The IMS Constitution is its governing document.

In the event of the charity being wound up, no member would be liable to contribute towards the organisation's costs or payment of debts or liabilities.

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

The trustees who served during the year and up to the date of signature of the financial statements were: Prof N Panay Prof A Vincent Prof W Wolfman Prof T Simoncini Dr N Jaff Prof P Chedraui Prof S Palacios Prof A Pines MD (Completed term 18 October 2024) Prof X Ruan (Completed term 18 October 2024) Prof A Seng Bin Prof P Maki Prof S Cerdas (Completed term 18 October 2024) Prof R Nappi Prof S Goldstein Dr T Hillard (Elected 22 October 2024) Prof P Damodaran (Elected 22 October 2024) Prof A Cano (Elected 22 October 2024) Prof S Khandelwal (Elected 22 October 2024) Prof M Shapiro Dr P Schnatz (Elected 22 October 2024)

Organisational structure

Board of Directors

The oversight of the organisation's assets and strategic direction is the responsibility of its Trustees who are elected to the Board of Directors by the members of the Society. The Trustees serve a two-year term and may seek reelection for up to two additional terms. The Trustees elect a President, General Secretary and Treasurer who, along with the chairman of CAMS and the Past President, form the Executive Committee of the Board. The Trustees have complied with their duty outlined in section 4 of the Charities Act 2006 to have due regard to public benefit guidance issued by The Charity Commission. All Trustees engage in an induction programme that involves Trustee training on the organisation's work. This is coordinated by the President and the Chief Executive Officer (CEO).

Secretariat

The CEO is responsible for the strategic management and day to day running of the organisation. Pay and remuneration reviews are led by the President with support from the Officers.

The trustees' report was approved by the Board of Trustees.

Prof R Nappi

Trustee

Date: 31 October 2025

INTERNATIONAL MENOPAUSE SOCIETY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

The trustees who served during the year and up to the date of signature of the financial statements were: Prof N Panay Prof A Vincent Prof W Wolfman Prof T Simoncini Dr N Jaff Prof P Chedraui Prof S Palacios Prof A Pines MD (Resigned 18 October 2024) Prof X Ruan (Resigned 18 October 2024) Prof A Seng Bin Prof P Maki Prof S Cerdas (Resigned 18 October 2024) Prof R Nappi Prof S Goldstein Dr T Hillard (Appointed 22 October 2024) Prof P Damodaran (Appointed 22 October 2024) Prof A Cano (Appointed 22 October 2024) Prof S Khandelwal (Appointed 22 October 2024) Prof M Shapiro

Organisational structure Board of Directors

The oversight of the organisation's assets and strategic direction is the responsibility of its Trustees who are elected to the Board of Directors by the members of the Society. The Trustees serve a two-year term and may seek reelection for up to two additional terms. The Trustees elect a President, General Secretary and Treasurer who, along with the chairman of CAMS and the Past President, form the Executive Committee of the Board. The Trustees have complied with their duty outlined in section 4 of the Charities Act 2006 to have due regard to public benefit guidance issued by The Charity Commission. All Trustees engage in an induction programme that involves Trustee training on the organisation's work. This is coordinated by the President and the Chief Executive Officer (CEO).

Secretariat

The CEO is responsible for the strategic management and day to day running of the organisation. Pay and remuneration reviews are led by the President with support from the Officers.

The trustees' report was approved by the Board of Trustees.

................... Prof R Nappi Trustee

Date: 31st October 2025

INTERNATIONAL MENOPAUSE SOCIETY

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF INTERNATIONAL MENOPAUSE SOCIETY

I report to the trustees on my examination of the financial statements of International Menopause Society (the charity) for the year ended 31 December 2024.

Responsibilities and basis of report

As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011.

I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

Since the charity’s gross income exceeded £250,000, the independent examiner must be a member of a body listed in section 145 of the Charities Act 2011. I confirm that I am qualified to undertake the examination because I am a member of UK, which is one of the listed bodies.

Your attention is drawn to the fact that the charity has prepared the financial statements in accordance with the relevant version of the Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. I understand that this has been done in order for the financial statements to provide a true and fair view in accordance with UK Generally Accepted Accounting Practice.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Haines Watts Swindon Limited

Old Station House Station Approach Swindon Wiltshire SN1 3DU Date: 31st October 2025

INTERNATIONAL MENOPAUSE SOCIETY

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2024

Unrestricted
Restricted
funds
funds
2024
2024
Notes
£
£
Income from:
Donations and legacies
2
283,140
5,430
Charitable activities
3
380,642
-
Investments
4
106
-
Total income
663,888
5,430
Expenditure on:
Charitable activities
Support costs
5
576,936
-
World Congress
5
107,489
-
Webinars
5
44,826
-
IMPART Program
5
6,772
-
Total charitable
expenditure
736,023
-
Total expenditure
736,023
-
Net gains/(losses) on
investments
10
108,534
-
Net income/(expenditure) and
movement in funds
36,399
5,430
Reconciliation of funds:
Fund balances at 1 January
2024
1,610,947
16,146
Fund balances at 31
December 2024
1,647,346
21,576		 Total
Unrestricted
Restricted
funds
funds
2024
2023
2023
£
£
£
288,570
272,756
4,999
380,642
-
-
106
692
-
669,318
273,448
4,999
576,936
473,356
-
107,489
-
-
44,826
38,411
-
6,772
11,172
-
736,023
522,939
-
736,023
522,939
-
108,534
84,940
-
41,829
(164,551)
4,999
1,627,093
1,775,498
11,147
1,668,922
1,610,947
16,146		 Total
2023
£
277,755
-
692
278,447
473,356
-
38,411
11,172
522,939
522,939
84,940
(159,552)
1,786,645
1,627,093

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

INTERNATIONAL MENOPAUSE SOCIETY

BALANCE SHEET

AS AT 31 DECEMBER 2024

Notes
Fixed assets
Tangible assets
12
Investments
13
Current assets
Debtors
14
Cash at bank and in hand
Creditors: amounts falling due within
one year
15
Net current assets
Total assets less current liabilities
The funds of the charity
Restricted income funds
16
Unrestricted funds
17		 2024
£
£
2,431
1,465,307
1,467,738
341,772
73,154
414,926
(213,742)
201,184
1,668,922
21,576
1,647,346
1,668,922		 2023
£
£
3,038
1,406,773
1,409,811
316,120
98,773
414,893
(197,611)
217,282
1,627,093
16,146
1,610,947
1,627,093		 2023
£
£
3,038
1,406,773
1,409,811
316,120
98,773
414,893
(197,611)
217,282
1,627,093
16,146
1,610,947
1,627,093
1,409,811
217,282
1,627,093
16,146
1,610,947
1,627,093

The financial statements were approved by the trustees on 31st October 2025

Prof R Nappi Trustee

INTERNATIONAL MENOPAUSE SOCIETY

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2024

Notes
Cash flows from operating activities
Cash absorbed by operations
19
Investing activities
Purchase of tangible fixed assets
Purchase of fixed asset investments
Proceeds from disposal of other investments
Investment income received
Net cash generated from/(used in) investing
activities
Net cash generated from financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2024
£
-
-
40,794
106		 2023
£
£
£
(66,519)
(51,350)
(792)
(190,891)
-
692
40,900
(190,991)
-
-
(25,619)
(242,341)
98,773
341,114
73,154
98,773

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

1.1 Basis of preparation

The financial statements have been prepared in accordance with the charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The charity is a Public Benefit Entity as defined by FRS 102.

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

The are no significant uncertainties regarding the ability of the charity to continue as a going concern.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

1.5 Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings 20% reducing balance Computer equipment 20% reducing balance

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.7 Fixed asset investments

Listed investments are measured at fair value with changes in fair value being recognised in income or expenditure.

1.8 Taxation

The charity is exempt from tax on its charitable activities.

1.9 Retirement benefits

The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

1.10 Foreign exchange

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

1.11 Debtors and prepayments

Trade and other debtors are recognised at the settlement amount due after any trade discounts. Prepayments are valued at the amount prepaid net of any discounts.

1.12 Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount to settle the obligation can be measured or estimated reliably.

2 Income from donations and legacies

Unrestricted
Restricted
funds
funds
2024
2024
£
£
Regional meetings
56,878
-
Educational grants
136,847
-
Membership fees
89,415
-
EER donations
-
5,430
283,140
5,430
Income from charitable activities
World congress		 Total
Unrestricted
Restricted
Total
funds
funds
2024
2023
2023
2023
£
£
£
£
56,878
50,000
-
50,000
136,847
100,570
-
100,570
89,415
122,186
-
122,186
5,430
-
4,999
4,999
288,570
272,756
4,999
277,755
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
380,642
-		 Total
2023
£
50,000
100,570
122,186
4,999
277,755

3 Income from charitable activities

World congress

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

4 Income from investments

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Income from listed investments 106 692

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

5 Expenditure on charitable activities

Support
costs
World
Congress
Webinars
IMPART
Program
2024
2024
2024
2024
£
£
£
£
Direct costs
IMPART Program Expenses
-
-
-
6,772
World Congress Expenses
-
107,489
-
-
Webinars
-
-
44,826
-
-
107,489
44,826
6,772
Share of support and governance costs (see note 6)
Support
576,936
-
-
-
576,936
107,489
44,826
6,772
Analysis by fund
Unrestricted funds
576,936
107,489
44,826
6,772		 Total
2024
£
6,772
107,489
44,826
159,087
576,936
736,023
736,023		 Support
costs
Webinars
IMPART
Program
2023
2023
2023
£
£
£
-
-
11,172
-
-
-
-
38,411
-
-
38,411
11,172
473,356
-
-
473,356
38,411
11,172
473,356
38,411
11,172		 Total
2023
£
11,172
-
38,411
49,583
473,356
522,939
522,939

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

6 Support costs allocated to activities

6
Support costs allocated to activities
Staff costs
Depreciation
Other
Analysed between:
Support costs
7
Net movement in funds
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements
Depreciation of owned tangible fixed assets		 2024
£
257,287
607
319,042
576,936
576,936
2024
£
-
607		 2023
£
192,910
759
279,687
473,356
473,356
2023
£
-
759

8 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year.

9 Employees

The average monthly number of employees during the year was:

Employment costs
Wages and salaries
Social security costs
Other pension costs		 2024
Number
5
2024
£
231,764
21,335
4,188
257,287		 2023
Number
3
2023
£
175,422
14,187
3,301
192,910

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

9 Employees

(Continued)

The number of employees whose annual remuneration was more than £60,000
is as follows:
£100,001 to £110,000
Remuneration of key management personnel
The remuneration of key management personnel was as follows:
Aggregate compensation		 2024
Number
1
2024
£
108,325		 2023
Number
1
2023
£
101,364

10 Gains and losses on investments

Unrestricted Unrestricted
funds funds
2024 2023
Gains/(losses) arising on: £ £
Revaluation of investments 108,534 84,940

11 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

12 Tangible fixed assets

Tangible fixed assets
Fixtures and
fittings
Computer
equipment
£
£
Cost
At 1 January 2024
362
5,546
At 31 December 2024
362
5,546
Depreciation and impairment
At 1 January 2024
177
2,693
Depreciation charged in the year
37
570
At 31 December 2024
214
3,263
Carrying amount
At 31 December 2024
148
2,283
At 31 December 2023
185
2,853		 Total
£
5,908
5,908
2,870
607
3,477
2,431
3,038

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

12 Tangible fixed assets

(Continued)

13 Fixed asset investments

Listed
investments
£
Cost or valuation
At 1 January 2024
1,215,882
Valuation changes
99,328
At 31 December 2024
1,315,210
Carrying amount
At 31 December 2024
1,315,210
At 31 December 2023
1,215,882		 Cash in
portfolio
£
190,891
(40,794)
150,097
150,097
190,891		 Total
£
1,406,773
58,534
1,465,307
1,465,307
1,406,773

At the year-end all listed investments represent unit trusts held by Shroders.

14
Debtors
Amounts falling due within one year:
Trade debtors
Prepayments and accrued income
15
Creditors: amounts falling due within one year
Taxation and social security
Accruals and deferred income		 2024
£
73,959
267,813
341,772
2024
£
7,469
206,273
213,742		 2023
£
252,767
63,353
316,120
2023
£
6,333
191,278
197,611

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

16 Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1 January Incoming At 31
2024 resources December
2024
£ £ £
16,146 5,430 21,576
Previous year: At 1 January Incoming At 31
2023 resources December
2023
£ £ £
11,147 4,999 16,146

EER - Endowment for Education and Research

The IMS has a well-established history of funding endeavours that promote education and research. This has included the Research Bursary, World Congress Travel Bursaries, and monetary prizes for IMS Awards. The Board of Directors recognizes the important role that funding plays in supporting vital initiatives to increase awareness and knowledge of menopause and midlife women's health. We also recognize that we are in a position to enhance our contribution to the field by generating and awarding more funding.

Therefore, the IMS Endowment for Education and Research (EER) was established on 4th August 2022, with the Young Scholars Bursary for the 18th World Congress on Menopause in Lisbon, Portugal as the first funded project. The EER is a vehicle through which the IMS provides funding for initiatives that support the delivery of the IMS mission: To work globally to promote and support access to best practice health care for women through their menopause transition and post-reproductive years, enabling them to achieve optimal health and well-being.

In addition to the IMS's own financial contribution to the EER, we aim to secure unrestricted funds via a variety of sources, including trusts and foundations grants, individual and major donor contributions, and fundraising campaigns. In addition to generating funds, this brings broader opportunities to grow support for our mission and build partnerships.

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

17 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At
General fund
IMPART Program - Online
training
Previous year:
At
General fund
IMPART Program - On-line
training		 1 January
2024
Incoming
resources
Resources
expended
Gains and
losses
At 31
December
2024
£
£
£
£
£
1,554,119
663,888
(729,251)
108,534
1,597,290
56,828
-
(6,772)
-
50,056
1,610,947
663,888
(736,023)
108,534
1,647,346
1 January
2023
Incoming
resources
Resources
expended
Gains and
losses
At 31
December
2023
£
£
£
£
£
1,707,498
273,448
(511,767)
84,940
1,554,119
68,000
-
(11,172)
-
56,828
1,775,498
273,448
(522,939)
84,940
1,610,947

IMPART Program

IMS received a grant from Pfizer (India) to create IMPART (International Menopause Society Professional Activity for Refresher Training). It is a self-learning, interactive, online course from IMS on Menopausal Health targeting health of 'aging' women. The course will be accessible free of cost to medical professionals globally - including PG students, Family Physicians and Practicing clinicians who treat post-menopausal women with a view to prevent or mitigate their health issues.

18 Related party transactions

There were no disclosable related party transactions during the year (2023 - none).

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

19 Cash absorbed by operations 2024 2023
£ £
Surplus/(deficit) for the year 41,829 (159,552)
Adjustments for:
Investment income recognised in statement of financial activities (106) (692)
Fair value gains and losses on investments (108,534) (84,940)
Depreciation and impairment of tangible fixed assets 607 759
Movements in working capital:
(Increase)/decrease in debtors (25,652) 116,159
Increase in creditors 25,337 76,916
Cash absorbed by operations (66,519) (51,350)